## Sexual Dysfunction and Alpha Blockers: Selectivity Matters **Key Point:** Sexual dysfunction (erectile dysfunction and retrograde ejaculation) is a selectivity-dependent side effect of α1 blockers. Among all available agents, **silodosin** has the highest α1A selectivity and the lowest incidence of sexual dysfunction, making it the best alternative when sexual function is a concern. ### Mechanism of Sexual Dysfunction with Alpha Blockers Alpha-1 adrenergic receptors are present in: - **Corpus cavernosum** (α1A and α1B): mediate penile smooth muscle contraction; α1 blockade reduces sympathetic tone, impairing normal erectile physiology - **Seminal vesicles, vas deferens, and bladder neck** (predominantly α1A): mediate coordinated ejaculation and bladder neck closure Non-selective or moderately selective α1 blockers cause: 1. **Erectile dysfunction**: α1 blockade in penile vasculature and corpus cavernosum reduces sympathetic tone required for normal erectile function 2. **Retrograde ejaculation**: α1 blockade at the bladder neck and proximal urethra prevents closure during ejaculation, directing seminal fluid retrograde into the bladder 3. **Reduced ejaculatory volume**: direct effect on seminal vesicle and vas deferens smooth muscle contraction ### Selectivity and Sexual Dysfunction Risk | Agent | α1A Selectivity | ED Incidence | Retrograde Ejaculation | Recommendation | |-------|-----------------|--------------|------------------------|----------------| | **Doxazosin** | Non-selective | High (5–10%) | High | Avoid in ED | | **Terazosin** | Non-selective | High (5–10%) | High | Avoid in ED | | **Prazosin** | Non-selective | High (5–10%) | High | Avoid in ED | | **Tamsulosin** | Moderate α1A | Moderate (2–4%) | Moderate (5–10%) | Consider switch | | **Alfuzosin** | α1A-selective | Low (1–2%) | Low | Good alternative | | **Silodosin** | **Highest α1A** | **Lowest (<1%)** | **Lowest** | **Best choice** | **High-Yield:** Silodosin is the most α1A-selective agent available and has the lowest incidence of erectile dysfunction and retrograde ejaculation among all alpha blockers. It is the preferred agent when preserving sexual function is a priority (KD Tripathi 8e, Ch 12). ### Why the Other Options Are Incorrect - **Option A (Alfuzosin):** Alfuzosin is α1A-selective and is a reasonable alternative, but the claim that it is "non-selective" is factually incorrect. It is uroselective (α1A-selective). While alfuzosin has a good sexual function profile, silodosin has demonstrably higher α1A selectivity. - **Option B (Doxazosin):** Doxazosin is non-selective and has the **highest** incidence of ED and retrograde ejaculation among alpha blockers. Non-selective α1 blockade does NOT improve erectile function — this is a common misconception. Vascular α1 blockade reduces systemic vascular resistance but impairs penile sympathetic tone. - **Option C (Prazosin):** Prazosin is non-selective, has a short half-life requiring multiple daily doses, and has a **high** incidence of sexual dysfunction. It is not preferred for BPH management. ### Management Algorithm When a BPH patient on an α1 blocker develops sexual dysfunction: 1. **Mild**: Counsel and continue; reassess 2. **Moderate**: Switch to silodosin (first choice) or alfuzosin (second choice) 3. **Severe**: Discontinue α1 blocker; consider 5α-reductase inhibitor; add PDE5 inhibitor if needed **Clinical Pearl:** Retrograde ejaculation caused by alpha blockers is **reversible** upon drug discontinuation. It is not harmful but significantly affects quality of life and patient satisfaction. Always counsel patients proactively. **Mnemonic:** **SILO** = **SI**lodosin = **LO**west sexual dysfunction risk among all alpha blockers. [cite: KD Tripathi 8e Ch 12; Campbell-Walsh Urology 12e]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.